Web Exclusives

For patients with recurrent metastatic HER2-positive breast cancer, new therapies such as margetuximab will expand treatment options. Read More ›

To help inform treatment decision-making, guidelines have been developed on surveillance mammography for early breast cancer survivors who are ≥75 years of age. Read More ›

Patients reported satisfaction with nurse-led telephone end-of-treatment follow-up experiences; therefore, permanent modifications may be warranted. Read More ›

Breast cancer survival disparities persist even after adjusting for sociodemographic factors, tumor characteristics, and NCCN guideline–appropriate treatment, suggesting that social and environmental factors can impact survival. Read More ›

Interfacility variation in efforts to eliminate the use of unnecessary breast cancer procedures highlights the need for more formalized deimplementation plans. Read More ›

In the cancer care setting, telehealth was perceived favorably by patients and providers, providing a new pathway for accessing treatment in the future. Read More ›

The pandemic shifted patients’ fears, highlighting the critical importance of physician trust and language used in recruitment. Read More ›

The delivery of care transformed rapidly as healthcare systems innovated to handle the COVID-19 pandemic. The overarching goals and principles of cancer care did not change, but there was a heightened recognition of the challenges faced by cancer patients. Read More ›

The latest quality-of-life research from the MONALEESA-7 trial supports a strong clinical benefit-to-risk ratio with ribociclib-based treatment in pre- and perimenopausal patients. Read More ›

In the future, telehealth may help overcome obstacles to healthcare access for underserved populations. Read More ›